Skip to content
Scailyte
  • Company
  • Discovery Engine
  • Pipeline
  • AIomics: IBD program
  • Resources
  • News
×
  • Company
  • Discovery Engine
  • Pipeline
  • AIomics: IBD program
  • Resources
  • News
Get in touch
Scailyte
  • Company
  • Discovery Engine
  • Pipeline
  • AIomics: IBD Program
  • Resources
  • News
×
  • Company
  • Discovery Engine
  • Pipeline
  • AIomics: IBD Program
  • Resources
  • News
Get in touch
Scailyte
  • Company
  • Discovery Engine
  • Pipeline
  • AIomics: IBD Program
  • Resources
  • News
×
  • Company
  • Discovery Engine
  • Pipeline
  • AIomics: IBD Program
  • Resources
  • News
Scailyte
  • Company
  • Discovery Engine
  • Pipeline
  • AIomics: IBD program
  • Resources
  • News
×
  • Company
  • Discovery Engine
  • Pipeline
  • AIomics: IBD program
  • Resources
  • News
Get in touch

Single-cell neural network classifiers reveal that PM21 NK cell expansion is dependent on B cell signaling

This study addressed the high variability in allogeneic NK cell expansion by applying ScaiVision to pre-expansion single-cell transcriptomics data. While standard methods failed, our AI approach unexpectedly uncovered a previously unknown supportive role for B cells in NK cell expansion, providing a blueprint for improving cell therapy manufacturing.

Continue reading
publication

Single-Cell RNA Sequencing of PBMCs Identified Junction Plakoglobin (JUP) as Stratification Biomarker for Endometriosis

This study aimed to identify unique characteristics in the peripheral blood mononuclear cells (PBMCs) of endometriosis patients and develop a non-invasive early diagnostic tool. Using single-cell RNA sequencing (scRNA-seq), we constructed the first single-cell atlas of PBMCs from endometriosis patients based on 107,964 cells and 25,847 genes.

Continue reading
publication

CNN-based learning of single-cell transcriptomes reveals a blood-detectable multi-cancer signature of brain metastasis

Scailyte’s pan-cancer brain metastasis signature, derived via single-cell RNA sequencing and ScaiVision AI, enables early detection, prognosis, and targeted therapy.

Continue reading
publication

Tracing Endometriosis: Coupling deeply phenotyped, single-cell based Endometrial Differences and AI for disease pathology and prediction

Scailyte’s single-cell atlas reveals key gene changes in endometriosis, offering new insights into pathophysiology, predictive models, and potential treatment targets.

Continue reading
publication

Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection (Cell Reports Medicine)

In this study, exploiting ScaiVision’s unique sensitivity, we were able to identify an immune population strongly linked to the development of complications from COVID associated with a high mortality rate.

Continue reading
publication

Sensitive detection of rare disease-associated cell subsets via representation learning (Nature Communications)

Original manuscript establishing the framework which laid the groundwork for our biomarker discovery platform ScaiVision. Initially designed for CyTOF data, we have now extended this framework for the integrative analysis of a large variety of data modalities enabling true multimodal analyses crucial for precision medicine.

Continue reading
publication
Scailyte

Contact Information:

Scailyte AG
Lichtstrasse 35
4056 Basel
Switzerland

  • LinkedInCreated with Sketch.
  • D3255223-CCD2-41A0-AFD7-7F9CA3058D9C

 

USA Contact Information:
Scailyte AG
c/o swissnex Boston
420 Broadway,
Cambridge, MA 02138,
USA

Get in touch

  • Careers
  • Contact us
  • Home
  • Company
  • Resources
  • News
  • Our Discovery Engine
  • Our Pipeline
Scailyte
Contact Information:

Scailyte AG
WSJ-500.1.101
Lichtstrasse 35
4056 Basel
Switzerland

  • LinkedInCreated with Sketch.
  • D3255223-CCD2-41A0-AFD7-7F9CA3058D9C
  • Clinical IVD Pipeline
  • ScaiVision
  • Partnering
  • Home
  • About
  • News
  • Careers
  • Contact us

Scailyte 2026 © All rights reserved. Scailyte, ScaiVision and the Scailyte logo are registered trademarks.

Terms & Conditions
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website you agree to our policies.